Sage/Biogen Announce Positive Results In Ph. 3 Coral Depression Drug Trial

Sage/Biogen Announce Positive Results in Ph. 3 CORAL Depression Drug Trial

HPR

FDA approves first postpartum depression pill from Biogen, Sage

Dr. Spencer Gibson: The 3 minute Thesis Showcase

The Leukemia & Lymphoma Society of Canada

Ep. 189 - Biogen-Sage Setback, Biotech IPOs, Sanofi Digital

BioCentury Video

Sage Therapeutics CEO on why its moving to treat depression next

CNBC Television

How a Clinical Trial for an Antidepressant Works | Shkreli Analyses Sage Therapeutics (SAGE) stock

The Shkreli Pill

Sage Therapeutics slumps, Biogen bounces

CNBC Television

Recovering from Setbacks, Sage Therapeutics to Develop Treatment for PPD & Major Depressive Disorder

Biogen shares drop despite positive Alzheimer's drug results

CNBC Television

SABCS 2024 highlights: assessing the clinical impact of EMBER-3 and PATINA

The first pill for postpartum depression! Zuranolone (Zurzuvae)

Improve Life PLLC

Biogen CEO: Alzheimer's drug shows positive results

CNBC Television

Biogen soars on promising results from Alzheimer's drug trial

CNBC Television

Episodic drugs provide hope for depression sufferers

CNBC Television

Zulresso (Brexanolone) New Treatment For Depression | Mark Agresti

Biogen alzheimer's drug shows positive results

CNBC Television

Clinical impact of POSITIVE trial

Two life changing side effects not described in current antidepressant labels

sGFAP: a potential diagnostic and prognostic marker in FTD

You're Still Okay, Even With Symptoms